Based on the Palisade Bio Inc stock forecast from 1 analysts, the average analyst target price for Palisade Bio Inc is USD 1.50 over the next 12 months. Palisade Bio Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Palisade Bio Inc is Bearish, which is based on 2 positive signals and 8 negative signals. At the last closing, Palisade Bio Inc’s stock price was USD 5.92. Palisade Bio Inc’s stock price has changed by +42.31% over the past week, +1,482.46% over the past month and -77.58% over the last year.
No recent analyst target price found for Palisade Bio Inc
No recent average analyst rating found for Palisade Bio Inc
Company Overview Palisade Bio Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Palisade Bio Inc (PALI)
Loading...
Unadjusted Closing Price for Palisade Bio Inc (PALI)
Loading...
Share Trading Volume for Palisade Bio Inc Shares
Loading...
Compare Performance of Palisade Bio Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for PALI
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Palisade Bio Inc (Sector: Biotechnology )
Frequently Asked Questions About Palisade Bio Inc (PALI) Stock
Based on ratings from 1 analysts Palisade Bio Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on PALI's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PALI is USD 1.50 over the next 12 months. The maximum analyst target price is USD 1.5 while the minimum anlayst target price is USD 1.5.
PALI stock's Price/Earning ratio is 1.13.
Our analysis grades PALI stock's Price / Earning ratio at C-. This means that PALI stock's Price/Earning ratio is above 30% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this PALI may be undervalued for its sector.
The last closing price of PALI's stock was USD 5.92.
The most recent market capitalization for PALI is USD 4.01M.
Based on targets from 1 analysts, the average taret price for PALI is projected at USD 1.50 over the next 12 months.
This means that PALI's stock price may go down by -74.66% over the next 12 months.
We can't find any ETFs which contains Palisade Bio Inc's stock.
Sorry, we do not have any data on the number of employees for Palisade Bio Inc.
Sorry we do not have any infomation available on Palisade Bio Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PALI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
